Security key
74365A309
Protalix BioTherapeutics, Inc. - Common Stock (PLX)
CUSIP: 74365A309
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 3,383,529
- Total 13F value
- $3,451,053
- Share change
- -2,087,873
- Put/Call ratio
- 59%
- SEC-reported price per share
- $1.02
- Number of holders
- 43
- Value change
- -$2,253,845
- Number of buys
- 10
- Number of sells
- 46
- Shares outstanding
- 80,610,558
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
43
Top holders
10
PLX full security history
Ownership snapshot
Full 13F holder table
Protalix BioTherapeutics, Inc. SEC filings
Protalix BioTherapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of PLX - Protalix BioTherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MILLENNIUM MANAGEMENT LLC
Disclosed value leader
MILLENNIUM MANAGEMENT LLC
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 1%
Showing 1-6 of 15 holder rows.
Quick read
MILLENNIUM MANAGEMENT LLC leads the comparable SEC ownership view at 1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MILLENNIUM MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
MILLENNIUM MANAGEMENT LLC
1%
RENAISSANCE TECHNOLOGIES LLC
1%
GOLDMAN SACHS GROUP INC
0.57%
NORTHERN TRUST CORP
0.53%
GSA CAPITAL PARTNERS LLP
0.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1%
|
$949,057
811,160 shares
|
— | 30 Jun 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1%
|
$941,382
804,600 shares
|
— | 30 Jun 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.57%
|
$540,491
461,958 shares
|
— | 30 Jun 2024 |
| NORTHERN TRUST CORP |
13F
Company
|
0.53%
|
$495,159
423,213 shares
|
— | 30 Jun 2024 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
0.5%
|
$469,000
401,244 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
0.41%
|
$389,810
333,171 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
3,383,529
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
64
Q3 2024 holders
43
Holder diff
-21
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|